Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week randomized double-blind placebo-controlled trial of alfuzosin in children with neuropathic voiding dysfunction
2004-002397-38Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of alfuzosin in Micturition disorder (3 arms), sponsored by Sanofi. Primary endpoint: Detrusor leak point pressure change from baseline to week 12. Started Jun 2007; status: completed.
02
Drugs
alfuzosin
03
Conditions
Micturition disorder
Beyond the preview
Go deeper on 2004-002397-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002397-38.